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Abstract: Since ancient times, plants have been used to preserve food, or for their health properties.
Essential oils are complex mixtures of volatile compounds that are obtained from botanical material,
specifically from aromatic plants. Lamiaceae is one of the most important families in the production
of essential oils, as it has both antioxidant and antimicrobial properties. The essential oils of Mentha
(the Lamiaceae family) have been extensively studied for their biological actions. In this review, we
report the antioxidant, antifungal, antibiofilm, and cytotoxic properties of Mentha spp. essential oils.
The first objective is to provide comprehensive information about the use of essential oils in the
treatment of fungal infections, or as antioxidants and integrative anticancer therapy. The second is to
explore the evidence supporting its effectiveness in treating diseases without causing any serious
adverse reactions.
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1. Introduction
Plant essential oils (EOs) are produced predominantly using steam distillation, but can also
be generated using fermentation, crushing, extraction, hydrolysis, and airing [1]. EOs are used
extensively in cosmetics in many different aspects as perfumes, in antiseptic applications, and in
domestic cleaning products [2,3]. They are volatile liquids or semi-liquids [4] that are limpid, but
are rarely colored, and are soluble in organic solvents. All of the organs of the plants can synthesize
EOs, which are stored in secretory compartments as cavities, canals, epidermic cells, or glandular
trichomes. EOs are complex mixtures of terpenoides containing sesquiterpene and monoterpene, and
their oxygenated derivatives. EOs may also incorporate a variety of other molecules such as fatty
acids, oxides, and sulfur derivatives [5]. Both the terpenoid and phenylpropanoid families, which
are sometimes identified as the principal constituents of several EOs, can constitute 85% of the total
concentration of the oil. There are about 3000 well-recognized EOs, of which 300 are widely sold [6].
Various factors influence the chemical compositions of EOs, such as their geographic location, the
seasonal period in which they are collected, the soil composition and cultivation method, their storage,
and the oil extraction method [7,8]. The high level of interest in research regarding EOs is due to
their many biological and medical properties [9]. They are generally recognized as safe, and they
can act synergistically with other compounds, which are promising factors for their use as bioactive
compounds [10].
Based on the number of search results in the PubMed database, the published studies on their
antimicrobial, antioxidant, and anti-tumoral activities are 2671, 1186, and 108, respectively [11].
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Mentha spp. Essential Oils
Many aromatic plants used in medicine, food, and pharmaceutical industries belong to the
Lamiaceae family. In this family, Mentha is a well-known genus that includes 25–30 species that are
generally grown in temperate areas around the world, particularly in Europe, North America, North
Africa, Asia Minor, the northern parts of Iran, and near the east (Syria, Ethiopia). Mentha spp. includes
plants that exhibit important biological activities and have high morphological variability and a great
chemical diversity with respect to their EOs [10].
For this reason, Mentha-derived EOs have been used as a folk remedy for respiratory diseases
such as bronchitis, sinusitis, tuberculosis, and the common cold [12]. Mentha acts as a good expectorant.
The chemistry of Mentha EOs is complex and high variable. The main constituents of the most
commonly used Mentha EOs revealed by gas chromatography–mass spectrometry (GC-MS) analysis
show the presence of menthol, menthone, limonene, isomenthone, menthyl acetate, carvone, β-pinene,
1,8-cineole, pulegone, piperitone oxide, and micene. Each species has a characteristic prevalent
compound (Figure 1). Studies that have already been carried out with Mentha spp. have shown
antimicrobial activity related to some species of this genus. The most cited activities of the plant are its
antiviral, antibacterial, antifungal [13], high antioxidant, and cytotoxic properties [14], and also other
properties such as its antinociceptive, anti-inflammatory, and antiallergic qualities [15]. This review
will focus on some of these properties.
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2. Antioxidant Properties
In recent years, th re has been an increasing interest in the consumption of EOs as natural
antioxidants [16]. It is well-known that reactive oxygen species (ROS) cause damage to cellular
macromolecules, and they are implicated in the development of many human diseases. Under many
pathological conditions the oxidation–reduction (redox) potential imbalance cannot remove excessive
amounts f ROS [17]. Oxidant species such as hydrogen peroxide (H2O2) and superoxide (O2−)
are produce following the phagocytosis of the pathogen by these cells as part of their machinery
to respond to harmful insults [18]. Excessive nitric oxide (NO) production and increased levels of
prooxidant species may lead to damage and poor perfusion of the vital organs of the host, contributing
to multiple organ failure; thus, to counteract this response, antioxidant pathways are activated [19].
Free radicals generated by damaged membranes, when combined with EOs, produce radicals with
scavenging activity.
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Natural antioxidants such as phenolic compounds can be found in many plants. The antioxidant
activity of essential oils does not always depend on its main component but can be modulated by other
components [20].
Antioxidant activity can be evaluated using various methods, and analytical tools are utilized
for measuring antioxidant content and total antioxidant capacity evaluation. The methods of
antioxidant capacity evaluation include counting spectrometry, chromatography, and electrochemical
techniques [21]. Generally, the most frequently used methods are DPPH (2,2-diphenyl-1-picrylhydrazyl),
ABTS (2,2’-azino-bis (3-ethylbenzthiazoline-6-sulphonic acid)), and others [22].
The main reaction occurring in spectrometric techniques is between a radical, radical cation,
or a complex and an antioxidant molecule donor of a hydrogen atom. DPPH (2,2-diphenyl-1-
picrylhydrazyl) is a stable free radical, and the assay is based on electron transfer that produces a
purple solution in ethanol, with an absorption band with a maximum of around 520 nm. When DPPH
reacts with a hydrogen donor, it generates the reduced molecular form (DPPH), and the purple color
disappears. The antioxidant concentration is linearly correlated with the absorbance diminution. The
standard antioxidant used is Trolox. The standard curve was linear between 25–800 mM Trolox [23].
The biamperometric antioxidant capacity assay also uses the redox couple ABTS+/ABTS. The
ABTS cation radical (ABTS+) [24], which absorbs at 743 nm (giving a green color), is formed by the loss
of an electron by the nitrogen atom of ABTS (2,2’-azino-bis (3-ethylbenzthiazoline-6-sulphonic acid)).
In the presence of Trolox (or another hydrogen-donating antioxidant), the nitrogen atom quenches
the hydrogen atom, causing the solution’s decolorization. ABTS can be oxidized by potassium
persulfate [24,25] or manganese dioxide [26]. The standard curve was linear between 25–600 µM of
Trolox. Unfortunately, the evaluation of the antioxidant activity of EOs remains a critical issue, because
many “tests” are unsuitable and provide contradictory results [27].
Mentha piperita L. is a plant native to the Mediterranean region that is popularly known as
peppermint; it is used medicinally for its antiproliferative and antioxidant actions. The plant is also
used worldwide, especially in the perfume and food industries, for its taste and fragrance.
Mentha piperita EO possesses antiradical activity with respect to DPPH and hydroxyl (OH−)
radicals; indeed, Schmidt et al. [28] have reported the antiradical activity of this EO for DPPH as (IC50),
while some authors have reported its radical scavenger activity against the ABTS radical [29].
Recently, similar results were confirmed by Sun et al. [30], specifically the action of peppermint
EO as a scavenger of hydroxyl radicals, and the potential for it to be an antioxidant at concentrations
≥200 µg/mL. da Silva Ramos et al. [31] reported an antioxidant activity of 79.9 ± 1.6% and IC50 =
414.6 µg/mL. On the contrary, other researchers [32] have described low antioxidant activity. More
probably, the antioxidant actions of M. piperita may be due to the presence of phenolic constituents
in its leaves, including rosmarinic acid and different flavonoids such as rutin, naringin, eriocitrin,
luteolin, and hesperidin, which are present in aqueous extracts [33,34], but not in the essential oil.
Furthermore, M. piperita EO is associated with increased levels of intracellular ROS, which is indicative
of an apoptotic process [35] without the loss of the plasma membrane integrity.
M. pulegium, another species of Mentha, has been used in traditional medicine to treat numerous
illnesses, such as microbial infections and oxidative stress. Kamkar et al. and Cherrat et al. [36,37] have
described the lower antioxidative activity of the M. pulegium EO with respect to aqueous or methanol
extracts. This difference could be due to a lack of diverse antioxidants in the EO. On the contrary, some
authors [38,39] have observed a good radical scavenging ability of M. pulegium EO compared with
ascorbic acid and Trolox.
Regarding other species of the genus Mentha used as antioxidants, Mentha spicata EO has been
used. In this case, different results were reported; some authors described the antioxidant activity of
M. spicata EO [40], while others [41] described a weak antioxidant activity.
Mentha longifolia L. (M. longifolia) is known as a wild mint named Puneh, and is a fast-growing
and perennial herb that creeps along an underground rootstock, which can grow to 1–2 m tall.
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Eissa et al. [42] revealed that M. longifolia EOs possesses the highest scavenging activity against
peroxyl radicals.
Mentha suaveolens Ehrh is a communal wild plant that is found near streams, bogs, and humid
places. There are different subspecies, each including several varieties. El-Askary et al. [43] reported a
potent antioxidant activity in vivo, which was about 96% relative to vitamin E, while Ferreira et al. [44]
described the AChE inhibitory capacity as higher than 50% in the essential oil fraction of M. suaveolens.
The antioxidant capacity in this case is due to piperitone oxide being present at 88% [45]. Other authors
have reported no relevant antioxidant activity for this species [46]. Some Mentha spp. have not been
assessed for antioxidant activity as yet. Table 1 reports antioxidant information about Mentha spp. EOs.
Table 1. Radical scavenging activity of Mentha essential oils (EOs). ABTS: 2,2’-azino-bis 3-ethylbenzthiazoline
-6-sulphonic acid, DPPH: 2,2-diphenyl-1-picrylhydrazyl.
EOs DPPH Activity ABTS Activity References
M. piperita
860 µg/mL - [28]
57.9 ± 1.34% 80.6 ± 1.45% [29]
600 µg/mL - [30]
540 µg/mL - [31]
11.289 ± 0.514 µg/g 0.154 ± 0.006 mmol/g [32]
M. pulegium
14736 ± 156 µg/mL - [36]
30.38 ± 0.8% - [37]
69.60 µg/mL - [38]
321.41 ± 2.53 µg/mL - [39]
M. spicata 3 µg/mL - [40]
3450 ± 172.5 µg/mL 40.2 ± 0.2 µg/mL [41]
M. longifolia 57.4 µg/mL - [42]
M. suaveolens 31 µg/mL - [43]
52.4 ± 2.5% - [44]
3. Antifungal Properties
A worldwide increase in the incidence of fungal infections has been observed, as well as the spread
of drug resistance among some species of fungus to different drugs used in medicinal practice [47].
Mycosis is a public health problem, particularly in tropical and subtropical developing countries.
Candida spp. is the most frequent pathogen in humans and animals. Azole-resistant Candida and
Aspergillus species are the pathogens that are responsible for nosocomial or food-borne infections.
Although C. albicans (CA) is the most commonly isolated species, there has also been a significant
increase in the frequency of other Candida species, such as C. parapsilosis, C. tropicalis, and C. glabrata.
There is emerging evidence from different parts of the world of the increasing resistance of CA and
non-CA species to antifungal agents such as triazoles and echinocandins, which are used in medicinal
practice [48].
Dermatophytes are a particular group of fungi that infect the keratinized tissues of humans and
animals. Infections caused by these fungi are probably the most common cutaneous fungal diseases.
Among the dermatophytes, Trichophyton mentagrophytes and Trichophyton rubrum are cosmopolitan
species, and are the most common agents of dermatophytoses. Among other filamentous fungi, the
most important is Microsporum canis, which is a worldwide distributed zoophilic dermatophyte that is
a recurrent cause of ringworm in humans, especially in young people [49].
Alternatives to conventional antimicrobial therapy have been studied to resolve this emergence.
Many Mentha species Eos, such as M. piperita, M. spicata, M. longifolia, M. pulegium, M. cervina, and
M. suaveolens have been used to evaluate antifungal activity against different species. Their antifungal
activity was evaluated by a variety of different protocols. The minimum inhibitory concentration
(MIC) is the lowest concentration of a drug that prevents the visible growth of a microorganism. It can
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be determined by culturing microorganisms in liquid media. Other studies have also reported the disk
diffusion method (DDA), which measures the sensitivity of microorganisms to antibiotics by culturing
microorganisms on solid growth media surrounding the sources of the drug.
Therefore, comparing the antifungal activity of different EOs is very difficult, as different methods
and ways of expressing concentrations have been used. Sometimes, some authors have reported
values of MIC as percent v/v, µL/mL, or µg/mL. It is more important to highlight that the essential
oil weight is about 1 g/mL. When the values of MIC were expressed in µL/mL, a few µL correspond
to milligrams of essential oil. The same is true when the MIC values were expressed in percentages. To
compare the values of MIC, we have transformed the concentration of all of the results into µg/mL, as
reported in Table 2.
Table 2 shows the antifungal activity of Mentha EOs against some human pathogenic fungi.
The genus that has been most investigated was Candida spp., followed by dermatophytes and
Aspergillus spp., M. piperita and M. suaveolens EOs have been studied more than M. spicata, M. longifolia,
M. pulegium, and M. cervinia. The method that has been more frequently used was a microbroth
dilution, rather than disk diffusion.
Table 2. Antifungal activity of Mentha spp. EOs against human pathogenic fungi.
Mentha spp.
Candida spp. Dermathophytes Aspergillus spp.
References
MIC 1 µg/mL DDA 2 mm MIC µg/mL DDA mm MIC µg/mL DDA mm
M. piperita
7120 - 3560 - - - [50]
44.5 - - - - - [51]
445 90 - - [16]
225 - - - - [52]
256 - - - - - [53]
- - −1335–2670 - 1335–2670 - [54]
1068–3560 - - - −445–3560 - [55]
890 - - - - - [56]
- - 890- - - - [57]
- - - - No activity - [58]
625 - - - 625 - [59]
M. spicata
- - 0.25 25 to 40 - - [60]
- - 890–2225 - 890–2225 - [54]
- - 512 - - - [61]
- - 1780–2670 - - - [62]
625 - - - 313 - [59]
M. longifolia 7120 - - - - - [50]
3.9 2.5 - - - - [63]
M. pulegium 890 16 - - 222.5 10 [64]
1112.5 19 - - - - [38]
M. cervinia 1112.5 to 2225 - 1112.5–2225 - 1112.5–2225 - [65]
M. suaveolens
0.03 to 0.24 - - - - - [66]
- - 53.4–111.25 - - - [67]
4 - - - 6.8 - [43]
390 to 780 - - - - - [68]
780 - - - - - [69]
760 to 1560 - - - - - [46]
780 17 to 35 - - - - [70]
Antifungal activity of Mentha spp. EOs. 1 MIC: minimum inhibitory concentration; 2 DDA: Disk Diffusion Agar
performed with 10 µL of essential oil.
It is possible to observe that the values of MIC that are reported are different. Indeed, the values of
MIC changed from 0.03 µg/mL, as reported by Oumzil et al. for M. suaveolens EO [66], to 7120 µg/mL
reported by Mimica-Dukic´ et al. for M. piperita and M. longifolia EOs [50].
Mimica-Dukic´ et al. [50] reported the antifungal activity of three EOs of the Mentha species
M. piperita, M. longifolia, and M. acquatica. The antifungal activity of M. piperita and M. longifolia EOs
that was evaluated against CA were 8 µL/mL, corresponding to about 7120 µg/mL of essential oil.
Moreover, the EOs of M. piperita and M. longifolia were found to be more active than that of M. aquatica.
M. piperita EO against Trichophyton tonsurans showed a MIC of 4 µL/mL, corresponding to about
3560 µg/mL. All of the values of MIC expressed in µL/mL are low; in reality, they are the highest.
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Tampieri et al. [51] reported values of MIC expressed in ppm (MIC = 500 ppm); when this
value was transformed into µg/mL, it corresponded to about 44.5 µg/mL. The antifungal activity of
M. piperita EO against a strain of CA was evaluated after seven days.
Other authors [52,53] have shown the antifungal activity of M. piperita EO with values of MIC of
225 µg/mL and 256 µg/mL, respectively, for CA performed by microbroth dilutions. High values of
MIC for Candida spp., dermatophytes, and Aspergillus spp. were reported by others [54–56]. Ibrahim
et al. [57] reported antifungal activity against dermatophytes at 890 µg/mL, while recently Ebani et
al. [58] did not demonstrate any antifungal effect at the highest dilution against Aspergillus fumigatus.
In addition, many authors have reported the antifungal activity of M. spicata EO, especially against
dermatophytes. Both the methods of disk diffusion and microbroth dilution were used.
Indeed, Sokovic´ et al. [54] reported the fungistatic activity of M. piperita in the macrodilution and
microdilution methods, with values of MIC of 1335 µg/mL to 2670 µg/mL in ethanol and 445 µg/mL
to 1335 µg/mL in Tween against Aspergillus spp. and dermatophytes. In addition, Sokovic et al.
reported the antifungal activity of some main compounds, such as 1–8 cineole, menthol, limonene,
and carvone, as shown in Table 3. Better activity was reported for M. spicata [54]. Similar results were
reported by Khoury et al. [61], with values of MIC of 512 µg/mL against Tricophitum rubrum, while
high values of MIC were reported by others [62] ranging from 2% v/v to 3% v/v and corresponding to
about 1780 µg/mL to 2670 µg/mL. Adam et al. [60] reported antifungal activity from 25 mm to 40 mm
for disk diffusion and 0.25 µg/mL for microbroth dilutions. M. spicata EO possesses greater fungistatic
activity than M. piperita EO against dermatophytes.
Table 3. Antifungal activity of main compounds of Mentha spp. Eos.
Compound MIC (µg/mL)
1,8 cineole 2760 to 7360
Menthol 220 to 1320
Limonene 500 to 1000
Carvone 240 to 960
The antifungal activity of M. longifolia EO against Candida spp. were reported by Ertas¸ et al. [63].
The activity was evaluated by both methods. The results were interesting, with values of MIC of
3.9 µg/mL.
Similar results were reported for M. pulegium EO against Candida spp. Indeed, two authors [38,64]
reported 19 mm and 16 mm for DDA and MIC values of about 1112.5 µg/mL and 890 µg/mL,
respectively. This EO was more active against Aspergillum spp. [64].
Goncalves et al. [65] showed the antifungal activity of M. cervina EO against yeasts, Aspergillus,
and dermatophyte strains. All of the species that were tested showed the same high values of MIC,
from 1250 µL/mL to 2500 µL/mL and corresponding to about 1112.5 µg/mL to 2225 µg/mL.
Oumzil et al. [66] described the antifungal activity of M. suaveolens EO against CA and C. glabrata.
The MIC values, which were expressed in ppm, were in the range of 0.34 to 2.77 ppm, corresponding
at about 0.03 µg/mL to 0.24 µg/mL. In addition, Angiolella et al. [67] reported the antifungal activity
of the same EO against different dermatophytes such as Trichophyton mentagrophytes and Microsporum
canis. Antimycotic activity was evident for dermatophytes with a range from 0.06% v/v to 0.125%
v/v, corresponding to about 53.4 25 µg/mL to 111.25 µg/mL for all of the strains of Trichophyton
mentagrophites, T. violaceum, Microsporum gypseum, and M. canis. El-Askary et al. [43] published the
antifungal activity of M. suaveolens EO against CA and Aspergillus niger, with low values of MIC
of 4 µg/mL, 5.2 µg/mL, and 6.8 µg/mL, respectively. High values of MIC have been obtained by
others [68,69] against CA, with MIC values from 390 µg/mL to 780 µg/mL. In addition, Spagnoletti
et al. [46] reported the antifungal activity of M. suaveolens EO against Candida spp., with MIC values
ranging from 760 µg/mL to1560 µg/mL. Scazzocchio et al. [70] confirmed the antifungal activity
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against different strains of CA that was sensitive or resistant to fluconazole. This activity has been
evaluated by both DDA and MIC.
The results of the antifungal activity of Mentha spp. EOs are highly divergent, and it is possible to
observe that M. suaveolens EO [66] was more active on Candida spp. than M. longifolia EO [63], followed
by M. piperita EO with MIC values of 225 µg/mL to 256 µg/mL [52,53]. M. spicata EO was more active
on dermatophytes, with values of MIC of 0.25 µg/mL [54], and Aspergillus spp. with an MIC value of
313 µg/mL [59], while M. suaveolens EO was more active on Aspergillus spp. with values of MIC of
6.8 µg/mL [43].
4. Antibiofilm Properties
About 65% of infections are caused by microorganisms developing on top of, rather than within,
the free-living planktonic state [71,72]. Biofilms are an association of microorganisms that are attached
to the surface and encased within a self-produced matrix of exopolymeric substances. Biofilms are
constituted by microorganisms with an extraordinary degree of organization. The Candida biofilm
consists of a heterogeneous structure that is composed of yeast and hyphae cells surrounded by a
self-secreted extracellular matrix. The Candida biofilm frequently shows resistance to conventional
antifungal drugs such as amphotericin B and fluconazole. During biofilm formation, an increase in
the metabolic activity was associated with an increase in antifungal resistance, which was coincident
with biofilm maturation [73]. Biofilm resistance constitutes an important factor in human disease. The
biofilm in Candida spp. represents an important virulence factor, and its reduction is very important
in combating infections. It is alarming that biofilm formation by Candida species may increase
resistance to antifungal therapy and protect the microbial cells from the host immune defenses [74].
The possibility of essential oils having potential antibiofilm activity has been studied by many authors.
Indeed, Agarwal et al. [75] reported the antibiofilm activity of 30 EOs against CA. Four EOs, including
eucalyptus, peppermint, ginger grass, and clove, showed 80.87%, 74.16%, 40.46%, and 28.57% biofilm
reduction, respectively. Saharkhiz et al. [55] described the inhibition of biofilm formation of CA
and C. dubliniensis with M. piperita EOs at concentrations of up to 2000 µg/mL. Stringaro et al. [69]
reported that M. suaveolens EO was able to reduce biofilm formation by about 80% at concentrations of
780 µg/mL and 1560 µg/mL in sensitive and resistant to fluconazole CA strains. Other authors, such
as Busato de Feiria et al. [76], observed the antibiofilm activity of three species of Mentha (M. aquatica,
M. arvensis, and M. piperita), which were able to inhibit biofilm formation and disrupt the mature
biofilm of CA MYA-2876. These EOs inhibited up to 50% of the biofilm formation at concentrations of
31 µg/mL, 25 µg/mL, and 4000 µg/mL.
5. Cytotoxic Activity
Cancer has been one of the most significant health problems over the last few years. It is a
multifactorial condition in which uncontrolled cell growth leads to the formation of solid tumors.
Finally, cancer cells invade healthy tissues. This process is known as metastasis.
Scientists are currently studying many synthetic drugs to hit and kill the dividing cells of various
tumors [77]. Unfortunately, the drugs that have been used in cancer therapy are not highly selective
for tumor cells, but also act against normal cells—mainly against cells with a high reproductive
index such as those of the blood. This unfortunately causes well-known side effects such as anemia.
Moreover, chemotherapy induces multidrug resistance, which is a phenomenon that demonstrates a
broad cross-resistance of cancer cells to various chemotherapeutic agents [78].
It has been recognized that various EO components act as multi-target molecules. With the aim of
developing novel antitumoral drugs, various EOs have showed high efficacies against human cancer
cells and low toxicity to human normal cells.
Many scientific studies have shown that some EO components, such as terpenes, have been
found to be effective against a broad range of cancers [79]. An example is geraniol, an acyclic dietary
monoterpene that is present primarily in roses and geraniums [80].
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An in vivo study in mice has demonstrated that 5-fluorouracil (20 mg/kg) and geraniol
(150 mg/kg) have an important impact against colon cancer. This administration reduces tumor
volume by 53%. A low reduction was obtained after a geraniol administration alone, while
5-fluorouracil showed no effect [81].
D-limonene, another monoterpene that is present in many EOs, has shown its efficacy both in vitro
and in vivo against many types of cancers. The scientific results of phase-I clinical trials indicated a
partial response in patients with different cancers [82].
Carvacrol and timol, which are phenol monoterpenes present in the EOs of oregano and thyme,
have shown an antiproliferative property in the cultured cells of several types of tumors such as lung,
liver, and colon cancers [83]. The genus of Mentha have also been shown to have many biological
activities, and especially anti-tumoral activity. Many studies have demonstrated the effect of Mentha
species EOs as inhibiting the cell proliferation of numerous tumor cells by acting on mitochondrial
dysfunctions, apoptosis induction, and autophagy processes [84].
Hajighasem et al. [85] demonstrated that an aqueous extract of Mentha spicata leaves has
cytotoxic effects on both mouse fibrosarcoma and human leukemia cell lines (Wehi-164), and on
human monocytic leukemia (U937) cells, in vitro. In addition, Bardaweel et al. [41] reported the
antiproliferative activities that are associated with Mentha spicata EO against three human cancer cell
lines. Sharma et al. [14] reported the activity of extracts of Mentha spp. against different human cancer
cell lines.
Moderate anticancer activity of M. longifolia EO on HepG-2, MCF-7, and A549 human tumor cell
lines at a concentration of 100 µg/mL has been reported by Abdel-Hameed et al. [86]. Under oxidative
stress conditions, M. longifolia oil prevented cell death and inhibited the ROS production that was
caused by H2O2 in a human astrocytoma cell line [42].
Mentha suaveolens plants that were collected in various regions of Morocco contained from 65%
to 90% of monoterpenes, oxides, terpenic, and terpenic ketones in their EOs. Recently, Mangone
et al. [87] studied the cytotoxicity of M. suaveolens EO on the human breast adenocarcinoma cell
line SKBR3. Analysis revealed a high percentage of piperitenone oxide, constituting 90% of the
EO [45,67]. In this study, the researchers evaluated the cellular metabolism of cancer cells by
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay after different treatment
with EOs at different times of incubation. Moreover, morphological and ultrastructural studies by
electron microscopy analysis were performed to understand the EOs’ cytotoxic action against SKBR3
human cancer cells (Figure 2). Scanning electron micrographs of human breast adenocarcinoma cells
treated with Mentha suaveolens EO for 24 h at 0.003 mg/mL are shown. Cells appeared damaged on
the plasma membrane, with many superficial alterations.
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In the field of biomedical research, both the transmission electron microscope (TEM) and
the scanning electron microscope (SEM) play an important role, especially when they are used
in association in correlative studies. In fact, they yield complementary morphological and
ultrastructural information.
The standard preparation procedure for electron microscopy requires fixation and
dehydration [88,89]. In studies of cancer cells, electron microscopes are instruments that produce
a largely magnified image by using electrons instead of light to form an image. TEM and SEM
microscopies allow us to study the ultrastructural details of biological samples, and in this case, it is
possible to see the changes induced by treatment with several types of agents such as drugs and natural
products as EOs. Moreover, it allows us to study the development of any pathological situations, as
well as any changes in environmental conditions.
Ultrastructural alterations in the plasma membrane, cytoplasm (swelling, shriveling, vacuolations,
leakage) and nucleus are revealed by SEM and TEM [90–92]. By electron microscopy analysis, Giordani
et al. [93] also demonstrated the plasma membrane alterations of human cancer cells after treatment
with an essential oil that was largely composed of monoterpenoids. Accordingly, the antimicrobic effect
of monoterpenoids [94] and monoterpenoids’ cytotoxic activities may produce alterations of lipidic
fractions and consequently changes in membrane properties. Different EOs or their main components
have been shown to induce caspase-dependent apoptosis in human cancer cells. In these cells, EOs can
provoke both mitochondrial membrane depolarization [95–97] and alterations of membrane fluidity,
which become abnormally permeable, resulting in the leakage of numerous molecules. Additionally,
as visible by SEM observations, the permeabilization of the outer and inner mitochondrial membranes
leads to cell death by apoptosis and necrosis (Figure 2) [98].
6. Side Effects and Toxicity
Numerous publications describe the toxicity of EOs, especially for humans, because despite them
being natural substances, whether they are safe is not certain. They are produced by plants in order to
protect themselves from parasites and insects, and prevent germination during the winter. For these
reasons, they could be toxic for human use, and they should always be used with caution. Toxicity can
be local or systemic, which is due to the composition of EOs. At first, the composition of EOs must be
verified by gas chromatography because composition and toxicity vary according to different factors
such as the seasonal period in which they are collected, the ecotype, the part of the plant from which
they are extracted, and the place where the oils are harvested [99–101]. The risk assessment of EOs
for human consumption is very important, particularly for vulnerable populations such us children
and pregnant women. Unfortunately, unlike with typical regulated drugs, rigorous scientific tests
have not been established for the safety of EOs. Toxicology studies in mice have revealed that Mentha
pulegium L. is hepatotoxic due to the ketone function of its volatile component, pulegone [99]. For this
reason, the maximum dose of this terpene in mint candies is 250 ppm [99], while in cosmetic products,
it should not exceed 1% [102], because it may cause irritation to the skin and mucous membranes [102].
Mentha spp. EOs are widely used for clinical purposes, mostly as an ingredient in creams for the
treatment of musculoskeletal pains and as an analgesic for arthritis due to its property of reducing
painful muscle spasms. Moreover, peppermint oil (Mentha piperita L.) is used for soothing headaches,
reducing spasms of the intestinal tract, and for symptoms of indigestion. It has a good antispasmodic
action that relaxes the gastrointestinal tract [12,103,104], and is also good for neuralgia.
Furthermore, toxicity can depend on the route of administration, and on the health conditions
of the individual using the EOs (damaged skin, allergy). Additionally, it depends on the additives
added to the oil. Unfortunately, there are many side effects related to Mentha spp. EOs, such as nausea,
allergic reactions, and flushing. These effects are due to the pharmacokinetic interactions that may
occur when EOs are taken together with conventional drugs. In particular, peppermint can interfere
with cytochrome P450; this cytochrome is fundamental in drugs and chemical metabolism [104].
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For this reason, anyone who produces the EOs and in particular Mentha spp. EOs should refer to
the guidelines published, for example, by the European Federation of Essential Oils (EFEO) or by the
International Fragrance Association (IFRA) for the correct characterization of the essential oil.
7. Conclusions
Mentha spp. EO has been used historically for several health conditions and exists in many
countries as a medicinal product with authorization. Mentha spp. EOs are employed in many fields
such as flavoring, medicine, cosmetology, and toiletries, but could represent an excellent opportunity
for integrative medicine to be used in combination with therapy for human health or could be useful
for extracting molecules to be used to formulate new drugs.
In this current review, only some biological properties of Mentha spp. EOs, such as their
antioxidant, antifungal, antibiofilm, and cytotoxic properties, are considered. It is very difficult
to compare studies on these factors, because there are many differences both in the extraction of the
essential oil and in the methods that are used to study its biological activities.
Many further studies are needed to understand the mechanism of action and to establish the
safety and non-toxicity of these EOs.
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